Details for New Drug Application (NDA): 208687
✉ Email this page to a colleague
NDA 208687 describes AZATHIOPRINE, which is a drug marketed by Alkem Labs Ltd, Amneal, Rising, Zydus Pharms Usa, and Hikma, and is included in five NDAs. It is available from ten suppliers. Additional details are available on the AZATHIOPRINE profile page.
The generic ingredient in AZATHIOPRINE is azathioprine sodium. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the azathioprine sodium profile page.
The generic ingredient in AZATHIOPRINE is azathioprine sodium. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the azathioprine sodium profile page.
Summary for 208687
| Tradename: | AZATHIOPRINE |
| Applicant: | Alkem Labs Ltd |
| Ingredient: | azathioprine |
| Patents: | 0 |
Pharmacology for NDA: 208687
| Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for 208687
Suppliers and Packaging for NDA: 208687
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| AZATHIOPRINE | azathioprine | TABLET;ORAL | 208687 | ANDA | Ascend Laboratories, LLC | 67877-492 | 67877-492-01 | 100 TABLET in 1 BOTTLE (67877-492-01) |
| AZATHIOPRINE | azathioprine | TABLET;ORAL | 208687 | ANDA | Ascend Laboratories, LLC | 67877-492 | 67877-492-05 | 500 TABLET in 1 BOTTLE (67877-492-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Mar 27, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Mar 27, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 75MG | ||||
| Approval Date: | Mar 27, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
